PatientWing
No information available
Featured Trial
Myelodysplastic Syndromes Clinical Trial
The goal of this study is to evaluate whether the investigational drug will help patients with lower-risk MDS improve their symptoms and reduce their number of transfusions.
Recruiting
Male & Female
18 Years +
Featured Trial
Primary Sclerosing Cholangitis Clinical Trial
This study is designed to assess the safety, tolerability and activity of CM-101 in patients with Primary Sclerosing Cholangitis (PSC).
Recruiting
Male & Female
18 - 75
Years old
Featured Trial
Higher-Risk MDS Study
Higher-Risk MDS Study
Recruiting
Male & Female
18 Years +
Featured Trial
Focal Onset Seizures Clinical Trial
The X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101 administered as adjunctive therapy in focal-onset seizures.
Recruiting
Male & Female
18 Years +
Featured Trial
IgG4-RD Clinical Trial
The purpose of this study is to learn if a new investigational medicine called obexelimab can safely help prevent flares associated with IgG4-related disease.
Recruiting
Male & Female
18 Milliseconds +
Featured Trial
Primary Generalized Tonic-Clonic Seizures Clinical Trial
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in primary generalized tonic-clonic seizures (PGTCS).
Recruiting
Male & Female
18 Years +
Featured Trial
Warm Autoimmune Hemolytic Anemia Clinical Trial
This study aims to examine the efficacy and safety of obexelimab in participants with Warm Autoimmune Hemolytic Anemia (wAIHA).
Recruiting
Male & Female
18 Years +
Featured Trial
PW TEST FOS
FOS Test
Recruiting
Female
All ages
Featured Trial
PW TEST PGTCS
PGTCS Test
Recruiting
Female
All ages
Featured Trial
HZN-1116-201
HZN-1116-201
Recruiting
Male & Female
18 - 75
Milliseconds old